Spark Therapeutics to Host Conference Call on Tuesday, Feb. 20 at 8:30 a.m. ET to Discuss 2017 Results and Recent Business Highlights
Spark Therapeutics Enters into a Licensing and Supply Agreement for Investigational Voretigene Neparvovec Outside the U.S.
Robert J. Perez is the managing partner of Vineyard Sound Advisors, which he founded in 2015 to provide advisory services to companies in the biopharmaceutical industry. He is also the founder and chairman of Life Science Cares, a nonprofit organization focused on fighting poverty in the greater Boston area.
He previously served as the chief executive officer of Cubist Pharmaceuticals, Inc. until its acquisition by Merck in 2015. Prior to his tenure as Cubist’s CEO, Rob held multiple roles since joining the company in 2003, including president, chief operating officer and senior vice president of sales and marketing, where he oversaw the launch of Cubicin (daptomycin for injection). He also held roles of varying commercial responsibilities in the industry, specifically leading Biogen’s central nervous system (CNS) commercial organization and as a regional business director at Zeneca Pharmaceuticals. He currently serves on the boards of directors at several public and private companies, including Vir Biotechnology, Akili Interactive Labs, Inc., AMAG Pharmaceuticals, Cidara Therapeutics, Zafgen, Inc. and Flex Pharma, Inc. He also serves on the board of trustees at Dana-Farber Cancer Institute.
Rob received a B.S. in business from California State University, Los Angeles and an M.B.A. from the Anderson Graduate School of Management at the University of California, Los Angeles.